Andrographolide: Progression in its modifications and applications-a patent review (2012-2014)

Expert Opinion on Therapeutic Patents

Volumn 24, Issue 10, 2014, Pages 1129-1138

  Aromdee, Chantana ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

analogs; andrographolide; anti inflammatory; anticancer; modification; therapeutic patent

Indexed keywords

14 DEOXY 11,12 DIDEHYDRO ANDROGRAPHOLIDE; ANDROGRAPHIS PANICULATA EXTRACT; ANDROGRAPHOLIDE; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BENZYLIDENE DERIVATIVE; DRUG ANALOG; LIPOPROTEIN; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG; DITERPENE; PLANT EXTRACT;

ANDROGRAPHIS PANICULATA; ANTIOXIDANT ACTIVITY; APOPTOSIS; BIOLOGICAL ACTIVITY; CANCER CELL; CHEMICAL MODIFICATION; CYCLIZATION; DRUG DEVELOPMENT; DRUG ISOLATION; EXTRACTION; HUMAN; ISOLATION PROCEDURE; NONHUMAN; REVIEW; SCREENING TEST; VIRUS; ANDROGRAPHIS; DRUG EFFECTS; PATENT; STRUCTURE ACTIVITY RELATION;

ANDROGRAPHIS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; APOPTOSIS; DITERPENES; HUMANS; NEUROPROTECTIVE AGENTS; PATENTS AS TOPIC; PLANT EXTRACTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84907271087     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2014.956084     Document Type: Review

References (71)

1. Council of Experts and its Expert Committees. The United States Pharmacopeia USP 36. U.S. Pharmacopeial Convention, Rockville, MD; 2013
2. Ministry of Public Health. Department of Medical Sciences. Thai herbal Pharmacopoeia. Prachachon Co. Ltd, Bangkok; 1995
3. Indian Pharmacopoeia Commission. Pharmacopoeia of India 1966. Manger of Publications, Delhi; 1970
4. State Pharmacopoeia Committee. Pharmacopoeia of Peoples Republic of China. Peoples Medical Publishing House, Beijing, China; 2010
5. Zhang F, Chen Q. Water-soluble derivative of andrographolide, its preparation and its applications in medicine. Faming Zhuanli Shenqing. CN103420961A 20131204; 2013
6. Faming Zhuanli Shenqing. Synthesis method of potassium and sodium dehydroandrographolide succinate. CN103113331; 2013
7. Faming Zhuanli Shenqing. Potassium sodium dehydroandrographolide succinate composition for injection and preparation method thereof. CN102657623; 2012
8. Tang C, Gu G, Wang B, et al. Design, synthesis, and biological evaluation of andrographolide derivatives as potent hepatoprotective agents. Chem Biol Drug Des 2014; 83: 324-33
9. Aromdee C. Modifications of andrographolide to increase some biological activities: a patent review (2006-2011). Expert Opin Ther Pat 2012; 22: 169-80
10. Aromdee C, Seubsasana S, Ekalaksananan T, et al. Stage of action of naturally occurring andrographolides and their semi-synthetic analogues against herpes simplex virus type 1 in vitro. Planta Med 2011; 77: 915-21
11. Sirion U, Kasemsook S, Suksen K, et al. New substituted C-19-andrographolide analogues with potent cytotoxic activities. Bioorg Med Chem Lett 2012; 22: 49-52
12. Chen M, Xie C, Liu L. Solubility of andrographolide in various solvents from (288.2 to 323.2). J Chem Eng Data 2010; 55: 5297-8
13. Faming Zhuanli Shenqing. Novel antiviral andrographolide derivative and its preparation. CN103739576; 2014
14. Faming Zhuanli Shenqing. Andrographolide compounds, their preparation method and medical application as antipyretic, anti-inflammatory, antiviral or antibacterial agents. Faming Zhuanli Shenqing. CN102250142A 20111123; 2011
15. Nanduri S, Nyavanandi VK, Rao SS, et al. Synthesis and structure-activity relationships of andrographolide analogues as a novel cytotoxic agents. Bioorg Med Chem Lett 2004; 14: 4711-17
16. Nateewattana J, Dutta S, Reabroi S, et al. Induction of apoptosis in cholangiocarcinoma by an andrographolide analogue is mediated through topoisomerase II alpha inhibition. Eur J Pharmacol 2014; 723: 148-55
17. Pandeti S, Sonkar R, Shukla A, Bhatia G. Synthesis of new andrographolide derivatives and evaluation of their antidyslipidemic, LDL-oxidation and antioxidant activity. Eur J Med Chem 2013; 439: e448
18. Wei S, Tang Y, Hua H, et al. Discovery of novel andrographolide derivatives as cytotoxic agents. Bioorg Med Chem Lett 2013; 23: 4056-60
19. Hazra A, Paira P, Sahu KB, et al. Chemistry of andrographolide: formation of novel di-spiropyrrolidino and di-spiropyrrolizidino-oxindole adducts via one-pot three-component [3+2] azomethine ylide cycloaddition. Tetrahedron Lett 2012; 5: 1585-8
20. Hazra A, Bharitkar YP, Chakraborty D, et al. Regio-and stereoselective synthesis of a library of bioactive dispiro-oxindolo/acenaphthoquino andrographolides via 1,3-dipolar cycloaddition reaction under microwave irradiation. ACS Comb Sci 2013; 15: 41-8
21. Guan SP, Kong LR, Cheng C, Lim JCW. Protective role of 14-deoxy-11,12-didehydroandrographolide, a noncytotoxic analogue of andrographolide, in allergic airway inflammation. J Nat Prod 2011; 74: 1484-90
22. Raghavan R, Cheriyamundath S, Madassery J. 14-Deoxy-11,12-didehydroandrographolide inhibits proliferation and induces GSH-dependent cell death of human promonocyticleukemic cells. J Nat Med 2014; 68: 387-94
23. Lai YH, Yu SL, Chen HY, et al. The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer. Carcinogenesis 2013; 34: 1069-80
24. Chen W, Feng L, Nie H, Zheng X. Andrographolide induces autophagic cell death in human liver cancer cells through cyclophilin D-mediated mitochondrial permeability transition pore. Carcinogenesis 2012; 33: 2190-8
25. Cheung MTW, Ramalingam R, Lau KK, et al. Cell type-dependent effects of andrographolide on human cancer cell lines. Life Sci 2012; 91: 751-60
26. Li J, Cheung HY, Zhang Z, et al. Andrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 cells via alteration of reactive oxygen species. Eur J Pharmacol 2007; 568: 31-44
27. Jada SR, Matthews C, Saad MS, et al. Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G1 arrest and apoptosis. Br J Pharmacol 2008; 155: 641-54
28. Dey SK, Bose D, Hazra A, et al. Cytotoxic activity and apoptosis-inducing potential of di-spiropyrrolidino and di-spiropyrrolizidino oxindole andrographolide derivatives. PLoS One 2013; 8: e58055
29. Hocker HJ, Cho KJ, Chen CYK, et al. Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function. Proc Natl Acad Sci USA 2013; 110: 10201-6
30. Chen D, Song Y, Lu Y, Xue X. Synthesis and in vitro cytotoxicity of andrographolide-19-oic acid analogues as anti-cancer agents. Bioorg Med Chem Lett 2013; 23: 3166-9
31. Gong C, Xu C, Ji L, Wang Z. A novel semi-synthetic andrographolide analogue A5 inhibits tumor angiogenesis via blocking the VEGFR2-p38/ERK1/2 signal pathway. BioSci Trends 2013; 7: 230-6
32. Xu H, Jiang P, Li W, et al. Synthesis and bioactivities of andrographolide derivatives: new (-)-limonidilactone analogues. Chin J Chem 2011; 29: 2114-18
33. Kasemsuk S, Sirion U, Suksen K, et al. 12-Amino-andrographolide analogues: synthesis and cytotoxic activity. Arch Pharm Res 2013; 36: 1454-64
34. Yao H, Li S, Yu P, et al. Reaction characteristics of andrographolide and its analogue AL-1 with GSH, as a simple chemical simulation of NF-B inhibition. Molecules 2012; 17: 728-39
35. Yan GR, Zhou HH, Wang Y, et al. Protective effects of andrographolide analogue AL-1 on ROS-induced RIN-mb cell death by inducing ROS generation. PLoS One 2013; 8: e63656
36. Zhang Z, Lai D, Wang L, Yu P. Neuroprotective effects of the andrographolide analogue AL-1 in the MPP+/MPTP-induced Parkinsons disease model in vitro and in mice. Pharmacol Biochem Behav 2014; 122: 191-202
37. Aromdee C, Cole ER, Crank G. Oxidation of 1,3-benzodithioles with lead tetraacetate. Aust J Chem 1983; 36: 2499-509
38. Packer L, Witt EH, Jorgen H, Tritschher J. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 227-50
39. Tang C, Liu Y, Wang B, et al. Synthesis and biological evaluation of andrographolide derivatives as potent anti-HIV agents. Arch Pharm Chem Life Sci 2012; 345: 647-56
40. Uttekar M, Das T, Rohan SP, et al. Anti-HIV activity of semisynthetic derivatives of andrographolide and computational study of HIV-1 gp120 protein binding. Eur J Med Chem 2012; 56: 368-74
41. Chen J, Chen H, Geng C, et al. 14-deoxy-14,15-didehydro andrographolide derivative useful in treatment of hepatitis B and its preparation. Faming Zhuanli Shenqing. CN103739597A 20140423; 2014
42. Chen H, Ma YB, Huang XY, et al. Synthesis, structure-activity relationships and biological evaluation of dehydroandrographolide and andrographolide derivatives as novel anti-hepatitis B virus agents. Bioorg Med Chem Lett 2014; 24: 2353-9
43. National University of Singapore. Use of andrographolide compounds for treating inflammation and airway disorders. US20120015923; 2012
44. Ma HY, Sun DX, Cao YF, et al. Herb-drug interaction prediction based on the high specific inhibition of 2 andrographolide derivatives towards UDP-glucuronosyltransferase 3 (UGT) 2B7. Toxicol Appl Pharmacol 2014; 277 (1): 86-94
45. Li XP, Zhang CL, Gao P, et al. Effects of andrographolide on the pharmacokinetics of aminophylline and doxofylline in rats. Drug Res (Stuttg) 2013; 63: 258-62
46. Chien CF, Wu YT, Lee WC, et al. Herb-drug interaction of Andrographis paniculata extract and andrographolide on the pharmacokinetics of theophylline in rats. Chem Biol Interact 2010; 184: 458-65
47. Hovhannisyan AH, Abrahamyan ES, Gabrielyan ES, Panossian AG. The effect of Kan Jang extract on the pharmacokinetics and pharmacodynamics of warfarin in rats. Phytomedicine 2006; 13: 318-23
48. Zhang ZR, Zaharna MA, Wong MM, et al. Taxifolin enhances andrographolide-induced mitotic arrest and apoptosis in human prostate cancer cells via spindle assembly checkpoint activation. PLoS One 2013; 8 (1): e54577
49. Bao GQ, Shen BY, Pan CP, et al. Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer. Toxicol Lett 2013; 222: 23-35
50. Faming Zhuanli Shenqing. Application of andrographolide combined with 5-fluorouracil (5-FU) in preparation of drugs for treating colon cancer by sensibilization. Faming Zhuanli Shenqing. CN103340870; 2013
51. Faming Zhuanli Shenqing. Natural pharmaceutical composition for treatment of cancer chemotherapy-induced diarrhea and synergistic treatment of cancer and preparation method thereof. CN103356720A 20131023; 2013
52. Yunos NM, Mutalip SM, Jauri MH, et al. Anti-proliferative and pro-apoptotic effects from sequenced combinations of andrographolide and cisplatin on ovarian cancer cell lines. Anticancer Res 2013; 33: 4365-72
53. Andrographolide injection. Available from: http://www.cqlummy.com. [Last access 28 July 2014]
54. Xiyanping injection andrographolide ester sulfonate. Available from: http://www.aqnovel.com. [Last access 28 July 2014]
55. Chen Q, Liu Y, Liu YM, et al. Pharmacokinetics and tolerance of dehydroandrographolide succinate injection after intravenous administration in healthy Chinese volunteers. Acta Pharmacol Sin 2012; 33 (10): 1332-6
56. Faming Zhuanli Shenqing. Andrographolide phosphoric acid derivatives, their preparation process and application in preparing the medical preparations as antiviral agent, anti-inflammatory agent, antibacterial agent, antitumor agent, cardioprotective agent or immunostimulant. Faming Zhuanli Shenqing. CN102399245; 2012
57. Faming Zhuanli Shenqing. Method for preparing effective component of Andrographis paniculata for preventing cancers. Faming Zhuanli Shenqing. CN102652762; 2012
58. Faming Zhuanli Shenqing. Arylene butenolide-containing Andrographolide derivative, its synthesis and application. Faming Zhuanli Shenqing. CN102838571; 2012
59. Faming Zhuanli Shenqing. Novel antiviral andrographolide derivative and its preparation. Faming Zhuanli Shenqing. CN103739576; 2014
60. Dai G, Xu H, Jiang Z, et al. Application of andrographolide C15-substituted series derivative in preparing medical preparations for resisting hepatitis B. Faming Zhuanli Shenqing. CN102302487A 20120104; 2012
61. PCT Int. Application of andrographolide C15-substituted series derivative in preparing medical preparations for resisting hepatitis B. WO2013004171; 2013
62. Faming Zhuanli Shenqing. Piperazine derivative and medicinal application antitumor agents, anti-inflammation agents, liver protection, anesthetic agent. CN103508981; 2014
63. Faming Zhuanli Shenqing. Applications of andrographolide sulfonate in manufacturing medicines for treating inflammatory bowel disease. CN103006640; 2014
64. Faming Zhuanli Shenqing. 19-carboxy-andrographolide derivatives, preparation method and medical application. Faming Zhuanli Shenqing. CN102964320; 2013
65. Faming Zhuanli Shenqing. Medicine composition and application thereof. Faming Zhuanli Shenqing. CN103463104; 2013
66. Faming Zhuanli Shenqing. 14-Aryl ether andrographolide derivative useful in treatment of FXR-related diseases and its preparation. CN103224492; 2013
67. Faming Zhuanli Shenqing. Andrographolide-19-amide derivative useful in treatment of cancer and its preparation. CN103588738; 2014
68. Faming Zhuanli Shenqing. Ent-labdane-type diterpene derivatives preparation method and anti-tumor application. CN103804330; 2014
69. Singh H, Williams RT, Guy K. BCR-ABL positive lymphoblastic leukemias. WO2013177420; 2013
70. Hancke O, Juan L, Burgos R. Combination therapy with interferon and andrographolides for multiple sclerosis. WO2013096423A1 20130627; 2013
71. Faming Zhuanli Shenqing. Neurodegenerative. CN103432118; 2013